We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » International Drugmakers Earn Warning Letters Over Quality Controls
International Drugmakers Earn Warning Letters Over Quality Controls
The FDA issued warning letters to two international drug manufacturers for breaching GMP standards by failing to develop procedures to maintain the appropriate quality controls.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor